Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modifying Young Adult Skin Cancer Risk and Protective Behaviors (UV4.me2): A Hybrid Type 2 Dissemination/Effectiveness Trial

NCT03313492 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT03313492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03313492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modifying Young Adult Skin Cancer Risk and Protective Behaviors (UV4.me2): A Hybrid Type 2 Dissemination/Effectiveness Trial
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Not applicable
Overall status
Completed
Start date
September 7, 2018
Completion date
July 31, 2020
Enrollment
1,746 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma and other malignant neoplasms of skin